Mainstream

Kymera extends cash runway to 2H 2028 as immunology pipeline advances and collaborations boost funding

Kymera extends cash runway to 2H 2028 as immunology pipeline advances and collaborations boost funding

Post ContentkymrRead More

You might also be interested in reading Price Waves Reveal Pivotal AVAX Support At $31 – Details.

August 11, 2025
In Mainstream